Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Immuron Ltd ADR stock

Learn how to easily invest in Immuron Ltd ADR stock.

Immuron Ltd ADR is a biotechnology business based in the US. Immuron Ltd ADR shares (IMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Immuron Ltd ADR employs 5 staff and has a trailing 12-month revenue of around $765,193.

How to buy Immuron Ltd ADR stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – IMRN. It's that simple.

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • Get $10 when you sign up and deposit $100

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Immuron Ltd ADR stock price (NASDAQ: IMRN)

Use our graph to track the performance of IMRN stocks over time.

Immuron Ltd ADR shares at a glance

Information last updated 2023-01-19.
Latest market close$2.23
52-week range$1.39 - $4.27
50-day moving average $2.02
200-day moving average $2.40
Wall St. target price$6.41
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.56

Buy Immuron Ltd ADR stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Immuron Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Immuron Ltd ADR price performance over time

Historical closes compared with the close of $2.225 from 2023-01-25

1 week (2023-01-19) 4.71%
1 month (2022-12-23) 16.49%
3 months (2022-10-26) 15.89%
6 months (2022-07-26) -6.51%
1 year (2022-01-26) -39.70%
2 years (2021-01-26) -70.49%
3 years (2020-01-23) 3.46
5 years (2018-01-26) 6.73

Immuron Ltd ADR financials

Revenue TTM $765,193
Gross profit TTM $523,502
Return on assets TTM -7.51%
Return on equity TTM -11.63%
Profit margin 0%
Book value $4.08
Market capitalisation $12.3 million

TTM: trailing 12 months

Immuron Ltd ADR share dividends

We're not expecting Immuron Ltd ADR to pay a dividend over the next 12 months.

Immuron Ltd ADR share price volatility

Over the last 12 months, Immuron Ltd ADR's shares have ranged in value from as little as $1.39 up to $4.265. A popular way to gauge a stock's volatility is its "beta".

IMRN.US volatility(beta: 1.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immuron Ltd ADR's is 1.3318. This would suggest that Immuron Ltd ADR's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Immuron Ltd ADR overview

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III registration trial to reduce the risk of contracting travelers' diarrhea in the United States, and Phase II field trial for Travelers' Diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in Phase I/IIa clinical trial for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. .

Frequently asked questions

What percentage of Immuron Ltd ADR is owned by institutions?
Currently 0.332% of Immuron Ltd ADR shares are held by institutions.
How many people work for Immuron Ltd ADR?
Latest data suggests 5 work at Immuron Ltd ADR.
When does the fiscal year end for Immuron Ltd ADR?
Immuron Ltd ADR's fiscal year ends in June.
Where is Immuron Ltd ADR based?
Immuron Ltd ADR's address is: 62 Lygon Street, Carlton, VIC, Australia, 3053
What is Immuron Ltd ADR's ISIN number?
Immuron Ltd ADR's international securities identification number is: US45254U1016
What is Immuron Ltd ADR's CUSIP number?
Immuron Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 45254U101

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site